Sign Up to like & get
recommendations!
0
Published in 2019 at "American Journal of Transplantation"
DOI: 10.1111/ajt.15330
Abstract: The impact of postreperfusion syndrome (PRS) during liver transplantation (LT) using donor livers with significant macrosteatosis is largely unknown. Clinical outcomes of all patients undergoing LT with donor livers with moderate macrosteatosis (30%‐60%) (N =…
read more here.
Keywords:
postreperfusion syndrome;
moderate macrosteatosis;
group;
macrosteatosis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Clinical Transplantation"
DOI: 10.1111/ctr.14587
Abstract: This study aimed to identify risk factors for postreperfusion syndrome (PRS) and its impact on LT outcomes.
read more here.
Keywords:
syndrome liver;
transplantation;
postreperfusion syndrome;
transplantation outcomes ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Transplant International"
DOI: 10.1111/tri.13314
Abstract: A double‐blind randomized controlled trial was performed to compare the safety and efficacy of α‐lipoic acid (ALA) in liver transplantation (LT). The grafts were randomized to receive ALA or placebo before the cold ischemia time.…
read more here.
Keywords:
ala;
postreperfusion syndrome;
liver transplantation;
postreperfusion ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Translational gastroenterology and hepatology"
DOI: 10.21037/tgh.2019.08.12
Abstract: In liver transplantation (LT), postreperfusion syndrome (PRS) is represented by a series of transient hemodynamic alterations occurring after graft reperfusion into the recipient, including bradycardia, dysrhythmia, decreased systemic vascular resistance and mean arterial pressure (MAP),…
read more here.
Keywords:
liver transplantation;
postreperfusion syndrome;